100X Gains On Tap as Under-the-Radar Green-Tech Stock Soars
Searching for the next 1,000% stock winner? Look no further than key Green-Techs that are driving the EV, Solar & 5G booms. Silver is the #1 element in the Green Energy Revolution & we’ve found the top silver gem – undiscovered at 10-cents per share – that’s fueling the path to a carbon-free world.
Get the details here...
pixel

IONS Insider Trading (Ionis Pharmaceuticals)

Insider Ownership Percentage: 2.40%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $19,376,818.93

Ionis Pharmaceuticals Insider Trading History Chart

Ionis Pharmaceuticals Share Price & Price History

$42.36
▼ -0.33 (-0.77%)
As of 04/9/2021 01:00 AM ET
Days: 30 | 90 | 365
The Real Stock Market Wealth Is Made... At 3pm!
Steady gains in 18 hours?? Pro traders call this the 3PM “burn window”… ACCESS NOW!
Continue Reading
pixel

Ionis Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/1/2021Brett P MoniaCEOSell236$54.28$12,810.0850,350  
1/26/2021Stanley T CrookeChairmanSell28,333$63.74$1,805,945.422,021  
1/25/2021Patrick R O'neilEVPSell5,324$63.50$338,074.0026,502  
1/21/2021Stanley T CrookeChairmanSell35,000$61.20$2,142,000.0030,354  
1/13/2021Richard S GearyEVPSell141$59.50$8,389.5030,306  
1/5/2021Eric SwayzeEVPSell195$55.99$10,918.055,107  
12/23/2020B Lynne ParshallDirectorSell10,000$60.00$600,000.0057,464  
12/17/2020Stanley T CrookeChairmanSell1,407$50.50$71,053.502,021  
12/15/2020Stanley T CrookeChairmanSell39,000$49.78$1,941,420.002,021  
12/7/2020Stanley T CrookeChairmanSell11,000$51.67$568,370.002,021  
12/4/2020Brett P MoniaCEOSell23,840$51.04$1,216,793.6052,719  
12/4/2020C Frank BennettInsiderSell7,947$51.04$405,614.8840,423  
12/2/2020Brett P MoniaCEOSell21,160$51.32$1,085,931.2050,039  
12/2/2020C Frank BennettInsiderSell7,053$51.32$361,959.9639,529  
11/25/2020B Lynne ParshallDirectorSell3,590$50.05$179,679.5071,054  
11/25/2020Elizabeth L HougenCFOSell21,680$50.05$1,085,084.0054,175  
11/25/2020Stanley T CrookeChairmanSell12,990$50.05$650,149.5015,011  
11/24/2020Richard S GearyEVPSell2,380$50.83$120,975.4041,147  
11/23/2020B Lynne ParshallDirectorSell3,200$50.12$160,384.0070,664  
11/23/2020Elizabeth L HougenCFOSell19,000$50.11$952,090.0045,620  
11/23/2020Stanley T CrookeChairmanSell11,600$50.11$581,276.0013,621  
11/3/2020C Frank BennettInsiderSell15,000$46.77$701,550.0047,476  
10/20/2020Joseph Klein IIIDirectorSell2,889$46.86$135,378.5413,794  
9/21/2020Stanley T CrookeChairmanSell2,000$50.18$100,360.002,021  
9/1/2020Brett P MoniaCEOSell314$53.70$16,861.8029,193  
6/25/2020Breaux CastlemanDirectorSell10,000$60.00$600,000.0025,183  
6/25/2020C Frank BennettEVPSell15,000$59.77$896,550.0047,364  
6/24/2020Stanley T CrookeChairmanSell5,000$58.80$294,000.0011,935  
6/23/2020Spencer R BerthelsenDirectorSell15,000$58.76$881,400.00111,983  
6/19/2020Stanley T CrookeChairmanSell10,000$58.33$583,300.0026,935  
6/17/2020Stanley T CrookeChairmanSell15,000$57.90$868,500.0026,935  
3/25/2020Stanley T CrookeChairmanSell15,000$47.00$705,000.0041,935  
3/19/2020Stanley T CrookeChairmanSell15,000$45.17$677,550.0061,545  
2/10/2020Patrick R O'neilSVPSell3,882$59.60$231,367.2020,720  
1/2/2020Brett P MoniaCEOSell173$60.25$10,423.2516,285  
12/23/2019Joseph Klein IIIDirectorSell1,000$61.87$61,870.0013,683  
12/16/2019Joseph Klein IIIDirectorSell1,000$65.45$65,450.0013,683  
12/9/2019Joseph Klein IIIDirectorSell1,000$63.74$63,740.0013,683  
12/4/2019Elizabeth L HougenCFOSell4,566$64.61$295,009.26
12/4/2019Richard S GearySVPSell10,000$64.61$646,100.00
12/2/2019Joseph Klein IIIDirectorSell1,000$64.08$64,080.0013,683  
12/2/2019Richard S GearySVPSell5,000$65.06$325,300.0026,583  
11/25/2019Elizabeth L HougenCFOSell4,000$62.50$250,000.0024,055  
11/25/2019Joseph Klein IIIDirectorSell812$62.90$51,074.8012,683  
11/20/2019Brett P MoniaCOOSell5,776$60.01$346,617.7616,458  
11/20/2019Joseph Klein IIIDirectorSell2,000$60.00$120,000.0013,495  
11/19/2019Elizabeth L HougenCFOSell4,000$58.80$235,200.0024,055  
8/21/2019Stanley T CrookeChairmanSell22,000$71.52$1,573,440.0079,634  
7/18/2019Stanley T CrookeCEOSell10,000$70.25$702,500.0079,634  
7/2/2019Brett P MoniaCOOSell210$66.40$13,944.0022,444  
6/24/2019Spencer R BerthelsenDirectorSell15,000$63.67$955,050.0099,404  
6/4/2019Frederick T MutoDirectorSell15,000$65.29$979,350.0024,794  
5/6/2019Frederick T MutoDirectorSell8,000$72.75$582,000.0017,794  
4/29/2019B Lynne ParshallDirectorSell50,000$75.01$3,750,500.00102,677  
4/16/2019Stanley T CrookeChairmanSell32,000$84.84$2,714,880.0079,634  
4/8/2019Richard S GearySVPSell46,240$84.01$3,884,622.4045,442  
4/5/2019Patrick R O'neilSVPSell49,528$83.99$4,159,856.7227,327  
4/3/2019Patrick R O'neilSVPSell7,654$84.83$649,288.8227,327  
3/19/2019Joseph H WenderDirectorSell10,000$79.63$796,300.00  
3/18/2019Patrick R O'neilSVPSell28,800$78.79$2,269,152.0048,473  
3/12/2019B Lynne ParshallDirectorSell8,334$75.00$625,050.0061,011  
2/27/2019B Lynne ParshallDirectorSell8,333$70.00$583,310.0061,010  
2/27/2019Patrick R O'neilSVPSell26,800$68.01$1,822,668.0024,373  
2/26/2019Stanley T CrookeChairmanSell77,000$60.77$4,679,290.00109,634  
2/13/2019Richard S GearySVPSell999$60.00$59,940.0021,442  
2/13/2019Stanley T CrookeChairmanSell46,904$60.09$2,818,461.36109,634  
2/5/2019Patrick R O'neilSVPSell19,600$59.25$1,161,300.0023,673  
2/1/2019C Frank BennettSVPSell9,013$58.29$525,367.7733,541  
1/3/2019Patrick R O'neilSVPSell4,400$54.80$241,120.0014,584  
1/2/2019Brett P MoniaCOOSell214$53.50$11,449.0016,051  
12/19/2018Elizabeth L HougenSVPSell4,063$52.03$211,397.8916,774  
11/23/2018Brett P MoniaCOOSell34,000$55.00$1,870,000.0049,841  
11/1/2018C Frank BennettSVPSell12,500$49.54$619,250.0031,896  
8/27/2018Brett P MoniaCOOSell16,493$54.00$890,622.0024,834  
8/8/2018C Frank BennettSVPSell12,500$45.00$562,500.0019,409  
7/24/2018Brett P MoniaCOOSell156$47.03$7,336.6815,841  
6/25/2018Spencer R BerthelsenDirectorSell15,000$42.30$634,500.0097,127  
5/31/2018Frederick T MutoDirectorSell15,000$46.45$696,750.0022,127  
5/11/2018C Frank BennettSVPSell12,500$45.00$562,500.0031,614  
5/11/2018Joseph H WenderDirectorSell15,000$45.31$679,650.0036,649  
4/17/2018Stanley T CrookeChairmanSell13,962$44.40$619,912.8056,714  
See Full Table

SEC Filings (Institutional Ownership Changes) for Ionis Pharmaceuticals (NASDAQ:IONS)

84.14% of Ionis Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Ionis Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
4/5/2021Pacer Advisors Inc.1,471$66K0.0%-48.9%0.001%
3/19/2021Baron Silver Stevens Financial Advisors LLC1,000$56K0.0%N/A0.001%
3/12/2021DekaBank Deutsche Girozentrale116,150$6.63M0.0%+6.0%0.082%
3/9/2021Defined Wealth Management LLC2,475$0.14M0.1%N/A0.002%
3/9/2021Childress Capital Advisors LLC543$31K0.0%N/A0.000%
3/9/2021Amundi Pioneer Asset Management Inc.64,457$3.64M0.0%+34.0%0.046%
3/8/2021Dimensional Fund Advisors LP449,104$25.40M0.0%-0.5%0.319%
3/4/2021Hudson Bay Capital Management LP160,000$9.05M0.1%+28.0%0.114%
3/4/2021Eaton Vance Management26,470$1.50M0.0%+2.1%0.019%
3/2/2021Norges Bank760,425$42.99M0.0%N/A0.540%
3/1/2021UBS Asset Management Americas Inc.409,511$23.15M0.0%+17.4%0.291%
2/25/2021Dimensional Fund Advisors LP449,104$25.40M0.0%-0.5%0.321%
2/25/2021Hsbc Holdings PLC17,334$0.98M0.0%-59.9%0.012%
2/24/2021Alyeska Investment Group L.P.202,477$11.45M0.2%N/A0.145%
2/23/2021Principal Financial Group Inc.41,026$2.32M0.0%-4.1%0.029%
2/19/2021PFM Health Sciences LP263,412$14.89M0.5%N/A0.188%
2/19/2021JPMorgan Chase & Co.1,873,332$105.92M0.0%+157.4%1.340%
2/19/2021AtonRa Partners7,817$0.44M0.2%N/A0.006%
2/19/2021International Biotechnology Trust PLC77,781$4.40M1.2%+95.5%0.056%
2/18/2021Truist Financial Corp20,941$1.18M0.0%+82.7%0.015%
2/17/2021Canada Pension Plan Investment Board42,687$2.41M0.0%+107.0%0.031%
2/17/2021Cetera Investment Advisers6,377$0.36M0.0%+50.9%0.005%
2/16/2021Tokio Marine Asset Management Co. Ltd.17,100$0.97M0.1%+13.2%0.012%
2/16/2021Squarepoint Ops LLC103,490$5.85M0.0%+50.9%0.074%
2/16/2021Alyeska Investment Group L.P.202,477$11.45M0.2%N/A0.145%
2/16/2021Brookfield Asset Management Inc.18,513$1.05M0.0%N/A0.013%
2/16/2021Morgan Stanley423,135$23.92M0.0%+120.3%0.303%
2/16/2021Nuveen Asset Management LLC606,566$34.30M0.0%+42.1%0.434%
2/16/2021Guggenheim Capital LLC60,854$3.44M0.0%-18.0%0.044%
2/16/2021Price T Rowe Associates Inc. MD13,114,967$741.52M0.1%+22.2%9.380%
2/16/2021Amundi Pioneer Asset Management Inc.64,457$3.64M0.0%+34.0%0.046%
2/16/2021Jefferies Group LLC19,976$1.13M0.0%N/A0.014%
2/16/2021ETF Managers Group LLC6,037$0.35M0.0%+12.7%0.004%
2/16/2021Engineers Gate Manager LP7,120$0.40M0.0%-50.1%0.005%
2/16/2021Gyon Technologies Capital Management LP13,616$0.77M0.3%+140.9%0.010%
2/16/2021Janus Henderson Group PLC50,626$2.86M0.0%-16.6%0.036%
2/16/2021Charles Schwab Investment Management Inc.691,409$39.09M0.0%+1.5%0.494%
2/12/2021Stifel Financial Corp364,242$20.60M0.0%+0.8%0.261%
2/12/2021Brown Advisory Securities LLC5,175$0.29M0.1%-4.6%0.004%
2/12/2021Raymond James Financial Services Advisors Inc.18,362$1.04M0.0%+25.0%0.013%
2/12/2021LPL Financial LLC53,079$3M0.0%+6.5%0.038%
2/12/2021Public Employees Retirement System of Ohio64,194$3.63M0.0%+23.9%0.046%
2/12/2021Alpha Paradigm Partners LLC5,348$0.30M0.1%N/A0.004%
2/12/2021Nomura Asset Management Co. Ltd.22,800$1.29M0.0%+0.9%0.016%
2/12/2021Eaton Vance Management26,470$1.50M0.0%+2.1%0.019%
2/12/2021Kennedy Capital Management Inc.6,211$0.35M0.0%N/A0.004%
2/12/2021Virtus ETF Advisers LLC12,725$0.72M0.3%+27.1%0.009%
2/11/2021Nikko Asset Management Americas Inc.323,168$18.27M0.1%+41.9%0.231%
2/11/2021Tanaka Capital Management Inc.16,806$0.95M2.1%-9.3%0.012%
2/11/2021Northern Trust Corp825,174$46.66M0.0%-0.8%0.590%
2/11/2021Majedie Asset Management Ltd113,836$6.44M0.5%+24.3%0.081%
2/11/2021Handelsbanken Fonder AB26,611$1.51M0.0%+19.3%0.019%
2/11/2021Teacher Retirement System of Texas25,829$1.46M0.0%+14.4%0.018%
2/11/2021Alexandria Capital LLC17,792$1.01M0.1%-1.1%0.013%
2/11/2021Oppenheimer Asset Management Inc.10,190$0.58M0.0%-9.6%0.007%
2/11/2021Xponance Inc.6,780$0.38M0.0%+3.2%0.005%
2/11/2021Veriti Management LLC1,602$91K0.0%N/A0.001%
2/10/2021Rhumbline Advisers151,811$8.58M0.0%-1.7%0.109%
2/10/2021Renaissance Technologies LLC745,348$42.14M0.0%-49.2%0.533%
2/10/2021Reynders McVeigh Capital Management LLC16,895$0.96M0.1%+4.9%0.012%
2/10/2021TD Ameritrade Investment Management LLC5,000$0.28M0.0%N/A0.004%
2/10/2021Clearbridge Investments LLC6,915,147$390.98M0.3%-4.9%4.946%
2/10/2021Baillie Gifford & Co.126,218$7.14M0.0%-97.4%0.090%
2/10/2021Aviva PLC25,809$1.46M0.0%-42.5%0.018%
2/10/2021Panagora Asset Management Inc.9,999$0.57M0.0%-18.9%0.007%
2/10/2021Korea Investment CORP38,900$2.20M0.0%+13.1%0.028%
2/10/2021HighTower Advisors LLC15,082$0.85M0.0%+26.1%0.011%
2/9/2021Advisory Services Network LLC1,169$66K0.0%+103.7%0.001%
2/9/2021Van ECK Associates Corp126,643$7.16M0.0%+0.6%0.091%
2/9/2021Bank of New York Mellon Corp569,994$32.23M0.0%+4.1%0.408%
2/9/2021Illinois Municipal Retirement Fund6,118$0.35M0.0%+154.6%0.004%
2/9/2021Mitchell & Pahl Private Wealth LLC7,021$0.40M0.3%N/A0.005%
2/9/2021Nicollet Investment Management Inc.10,869$0.62M0.3%+4.9%0.008%
2/9/2021Mitsubishi UFJ Kokusai Asset Management Co. Ltd.30,958$1.75M0.0%+17.9%0.022%
2/9/2021ProShare Advisors LLC24,090$1.36M0.0%-3.4%0.017%
2/9/2021Profund Advisors LLC28,489$1.61M0.1%+9.7%0.020%
2/8/2021Alliancebernstein L.P.69,069$3.91M0.0%-0.9%0.049%
2/8/2021Wrapmanager Inc.10,549$0.60M0.2%-5.0%0.008%
2/8/2021FDx Advisors Inc.7,184$0.41M0.0%+16.6%0.005%
2/8/2021State Board of Administration of Florida Retirement System175,653$9.93M0.0%-1.2%0.126%
2/8/2021Sei Investments Co.26,651$1.46M0.0%-68.7%0.019%
2/8/2021FMR LLC20,938,034$1.18B0.1%+0.3%14.975%
2/8/2021Nissay Asset Management Corp Japan ADV14,479$0.82M0.0%+5.7%0.010%
2/8/2021Russell Investments Group Ltd.65,059$3.68M0.0%-12.1%0.047%
2/6/2021AJO LP10,595$0.60M0.1%-82.2%0.008%
2/5/2021Aperio Group LLC30,251$1.71M0.0%-13.9%0.022%
2/5/2021Swiss National Bank501,659$28.36M0.0%-2.7%0.359%
2/5/2021NEXT Financial Group Inc2,829$0.16M0.0%+6.7%0.002%
2/5/2021Sumitomo Mitsui Trust Holdings Inc.764,684$43.24M0.0%+3.5%0.547%
2/5/2021Vestmark Advisory Solutions Inc.19,875$1.12M0.1%-3.2%0.014%
2/5/2021US Bancorp DE2,518$0.14M0.0%+55.9%0.002%
2/4/2021Daiwa Securities Group Inc.5,760$0.33M0.0%-8.4%0.004%
2/4/2021National Asset Management Inc.20,601$1.17M0.1%+4.8%0.015%
2/4/2021State of Wisconsin Investment Board100,085$5.66M0.0%+32.1%0.072%
2/3/2021State of New Jersey Common Pension Fund D96,182$5.44M0.0%-1.5%0.069%
2/2/2021Treasurer of the State of North Carolina50,115$2.83M0.0%+0.4%0.036%
2/2/2021California Public Employees Retirement System300,806$17.01M0.0%+0.9%0.215%
2/2/2021BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp22,419$1.27M0.0%-2.3%0.016%
2/2/2021First Trust Advisors LP1,386,931$78.42M0.1%-0.8%0.992%
2/2/2021Parallel Advisors LLC2,477$0.14M0.0%+172.2%0.002%
Data available starting January 2016

See Full Table
Ionis Pharmaceuticals logo
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial lipodystrophy. It is involved in developing neurology products that include Tominersen for Huntington's diseases; Tofersen for amyotrophic lateral sclerosis (ALS); IONIS-MAPTRx for Alzheimer's diseases; IONIS-C9Rx for genetic form of ALS; ION859 for Parkinson's disease; ION464 for multiple system atrophy and Parkinson's disease; ION541 for amyotrophic lateral sclerosis; and IONIS-DNM2-2.5Rx for centronuclear myopathy. The company is also developing products for cardiometabolic disease, such as IONIS-TTR-LRx for transthyretin amyloidosis and IONIS-GHR-LRx for acromegaly; IONIS-APOCIII-LRx for familial chylomicronemia syndrome and TG- driven diseases; IONIS-APOCIII-LRx for treatment resistant hypertension; Pelacarsen for Lp(a)cardiovascular disease risk reduction; Vupanorsen for sHTG/CVDRR; IONIS-FXI-LRx for clotting disorders; ION449 for cardiovascular diseases; and IONIS-GCGRRx for diabetics. In addition, it develops IONIS-ENAC-2.5Rx for cystic fibrosis and chronic obstructive pulmonary disease; IONIS-PKK-LRx for hereditary angioedema; Danvatirsen for cancer; IONIS-TMPRSS6-LRx for beta-thalassemia and iron toxicity; IONIS-HBVRx for hepatitis B virus; IONIS-AR-2.5Rx for prostate cancer; IONIS-FB-LRx for age-related macular degeneration and IgA nephropathy; and ION357 for retinitis pigmentosa. It has a collaboration agreement with AstraZeneca; GlaxoSmithKline plc; Janssen Biotech, Inc.; Bayer AG; Novartis AG; Pfizer, Inc.; Biogen Inc.; and Roche. Ionis Pharmaceuticals, Inc. was founded in 1989 and is based in Carlsbad, California.
Read More

Today's Range

Now: $42.36
$41.49
$42.98

50 Day Range

MA: $50.71
$42.51
$57.69

52 Week Range

Now: $42.36
$41.42
$64.37

Volume

2,113,189 shs

Average Volume

1,217,933 shs

Market Capitalization

$5.97 billion

P/E Ratio

88.25

Dividend Yield

N/A

Beta

1.42

Who are the company insiders with the largest holdings of Ionis Pharmaceuticals?

Ionis Pharmaceuticals' top insider investors include:
  1. Spencer R Berthelsen (Director)
  2. B Lynne Parshall (Director)
  3. Stanley T Crooke (CEO)
  4. Stanley T Crooke (Chairman)
  5. Elizabeth L Hougen (CFO)
  6. Brett P Monia (CEO)
  7. C Frank Bennett (Insider)
  8. C Frank Bennett (EVP)
  9. Richard S Geary (EVP)
  10. Richard S Geary (SVP)
  11. Patrick R O'neil (EVP)
  12. Breaux Castleman (Director)
  13. Frederick T Muto (Director)
  14. Brett P Monia (COO)
  15. Patrick R O'neil (SVP)
  16. Joseph Klein III (Director)
  17. Eric Swayze (EVP)

Who are the major institutional investors of Ionis Pharmaceuticals?

Ionis Pharmaceuticals' top institutional shareholders include:
  1. Pacer Advisors Inc. — 0.00%

Which institutional investors are selling Ionis Pharmaceuticals stock?

In the last quarter, IONS stock was sold by these institutional investors:
  1. Pacer Advisors Inc.
In the previous year, company insiders that have sold Ionis Pharmaceuticals company stock include:
  1. Spencer R Berthelsen (Director)
  2. B Lynne Parshall (Director)
  3. Stanley T Crooke (CEO)
  4. Stanley T Crooke (Chairman)
  5. Elizabeth L Hougen (CFO)
  6. Brett P Monia (CEO)
  7. C Frank Bennett (Insider)
  8. C Frank Bennett (EVP)
  9. Richard S Geary (EVP)
  10. Richard S Geary (SVP)
  11. Patrick R O'neil (EVP)
  12. Breaux Castleman (Director)
#1 trading secret
He started as a janitor’s grandson… and ended up becoming a million dollar hedge fund insider... Now he’s revealing the #1 trading secret he learned during his time on Wall Street…
Continue Reading
pixel